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Introduction: Recent studies have demonstrated that cortical brain areas tend to oscillate at a speciﬁc
natural frequency when directly perturbed by transcranial magnetic stimulation (TMS). Fast electro-
encephalographic (EEG) oscillations, which typically originate from frontal regions, have been reported
to be markedly reduced in schizophrenia.
Methods: Here we employed TMS/EEG to assess the natural frequency of the premotor area in a sample
of 48 age-matched participants (12 each in major depression disorder (MDD)), bipolar disorder (BPD),
schizophrenia (SCZ) and healthy controls. Event related spectral perturbations (ERSP) were obtained for
each study participant using wavelet decomposition.
Results: TMS resulted in a signiﬁcant activation of the beta/gamma band response (21–50 Hz) to frontal
cortical perturbation in healthy control subjects. By contrast, the main frequencies of frontal EEG
responses to TMS were signiﬁcantly reduced in patients with BPD, MDD and SCZ (11–27 Hz) relative to
healthy subjects.
Conclusions: Patients with bipolar disorder, major depression and schizophrenia showed a signiﬁcantly
lower natural frequency of frontal cortico-thalamocortical circuits compared to healthy controls. These
results suggest a common neurobiological mechanism of corticothalamic impairment. The most likely
candidates include dysfunction of GABAergic circuits.
Limitations: Further studies are needed to consider other biological markers, gene variants, and their
interaction with clinical variables.
& 2015 Elsevier B.V. All rights reserved.1. Introduction
High-frequency gamma oscillations are critical for commu-
nication among brain areas, thus allowing integration among
cortical modules (Nikolic et al., 2013; Rodriguez et al., 1999;
Whittington et al., 2000b). In the last decade clinical research on
oscillatory brain dynamics reported altered neuronal oscillations
in neuropsychiatric disorders (Basar, 2013; Basar and Guntekin,
2008; Herrmann and Demiralp, 2005; Uhlhaas and Singer, 2010),tario Ospedale San Raffaele,
urro, Via Stamira d'Ancona 20
).suggesting that reduced gamma oscillations could be common to
bipolar disorder (BPD), major depressive disorder (MDD) and
schizophrenia (SCZ) (Maharajh et al., 2007; O'Donnell et al.,
2004b).
Frontal cortical gamma activity (30–50 HZ), as indexed through
electroencephalography (EEG), is reduced in patients with SCZ
(Uhlhaas et al., 2008), in response to odd-ball paradigm (Gallinat
et al., 2004; Haig et al., 2000; Symond et al., 2005) or cognitive
control task (Cho et al., 2006). EEG power and phase synchroni-
zation in beta/gamma frequencies bands after to 40 Hz auditory
stimulation are also reduced (Kwon et al., 1999; Light et al., 2006).
Findings in mood disorders are similar. BPD patients in the manic
or mixed state show hampered auditory EEG synchronization in
beta/gamma band (20–50 Hz) during a click trains paradigm
P. Canali et al. / Journal of Affective Disorders 184 (2015) 111–115112(O'Donnell et al., 2004a), and reported signiﬁcantly reduced long
distance gamma coherence in a visual odd-ball paradigm (Ozer-
dem et al., 2010). A recent study reported a decrease of frontal
gamma oscillations in patients with MDD and BPD in response to
implicit emotional tasks (Lee et al., 2010; Liu et al., 2012). A
reduced phase locking and evoked power at 40-Hz auditory
steady-state stimulation in ﬁrst episode psychosis of patients with
either schizophrenia or affective disorders has also been reported
(Spencer et al., 2008).
The combination of transcranial magnetic stimulation with
high-density electroencephalographic recording (TMS/EEG)
represents a provocative approach useful to identify the integrity
of thalamocortical circuits by directly challenging the brain's
capacity to produce and sustain oscillatory activity (Buzsaki and
Watson, 2012; Canali, 2014; Rosanova et al., 2012). By combining
TMS/EEG we previously demonstrated that each cortical region
perturbed by TMS tend to oscillate at speciﬁc natural frequency
(Rosanova et al., 2009), and we found a deﬁcit in the oscillatory
properties in schizophrenia resulting in a reduction of frontal
natural frequencies (Ferrarelli et al., 2008; Ferrarelli et al., 2012).
Here we hypothesized impairments of the thalamocortical system
to produce fast oscillations in bipolar disorder and major depres-
sion. We then aimed at investigating the oscillatory properties of
the premotor cortex by employing TMS/EEG in two groups of
patients with bipolar disorder and major depression, and using a
group of healthy subjects as negative controls and a group of
patients with schizophrenia as positive controls.Table 1








Gender (m/f) 5/7 2/10 4/8 9/3
Age (yrs) 39 (15) 36 (7) 46 (8) 38 (9) 2.1 0.1
Age at onset
(yrs)
25 (6) 29 (9) 25 (6) 1.1 0.3
Duration of
illness (yrs)




















19.24 (5.03) 20.30 (4.22)
a Values are expressed as mean and standard deviations.2. Methods
We studied 12 healthy subjects as controls (HC), and 36 con-
secutively admitted inpatients suffering from three different psy-
chiatric disorders (DSM-IV criteria, SCID interview): either major
depressive episode, without psychotic features, in course of BPD
(n¼12) or in course of MDD (n¼12), or chronic undifferentiated
schizophrenia (n¼12). Inclusion criteria were the absence of other
diagnoses on axis I and of mental retardation on axis II; absence of
pregnancy, history of epilepsy, or major medical and neurologic
disorders; absence of a history of drug or alcohol dependency or
abuse within the last 6 months. Six BPD were taking lithium salts.
All MDD patients were on antidepressant treatment, also with
benzodiazepines (n¼8) or mood stabilizers (n¼3). SCZ patients
were taking antipsychotics (typical neuroleptics: n¼5; a typical
antipsychotics: n¼7). A written informed consent was obtained
for all study participants. The local ethics committee approved the
experimental protocol.
The experimental setup included a TMS compatible 60-channel
EEG ampliﬁer (Nexstim) equipped with sample-and-hold circuits
that prevents the recording from the powerful TMS-related artifact
(Virtanen et al., 1999). Accuracy and reproducibility of TMS/EEG
responses were controlled with a Navigated Brain Stimulation
(NBS) system (Nexstim) and a 3D-infrared Tracking Position Sen-
sor Unit (Northem Digital Inc). (For details of methods, see Rosa-
nova et al. (2009) and Supplementary materials.)
TMS was delivered on the convexity of the middle caudal
portion of the superior frontal gyrus close to the midline (Broad-
mann's areas 6), with the current perpendicular to its main axis. To
ensure signiﬁcant EEG responses (Casali et al., 2010; Komssi et al.,
2007; Rosanova et al., 2009) intensity of TMS induced electric ﬁeld
was always 490 V/m as estimated by the NBS system, for each
study participant. We delivered about 200–300 stimuli for each
session at a frequency randomly jittered between 1.5 and 1.8 s
(equivalent to about 0.5–0.6 Hz). (See Supplementary for detailed
description.)Data analysis was carried out using Matlab (The Mathworks
Inc.) with the EEGLAB toolbox (Delorme and Makeig, 2004). Each
TMS-evoked response was obtained by averaging 150–250 artifact
free trials. (For detailed TMS-evoked potential acquisition and
analyses, see Casali et al. (2010) and Supplementary materials.)
In order to quantify the responses in the time-frequency
domain (Delorme and Makeig, 2004), from each TMS/EEG session,
we measured the event-related spectral perturbation (ERSP)
changes in the power spectrum using wavelet decomposition (3.5
oscillation cycles) across single-trials at the channel closest to the
stimulation site. The ERSP was normalized by subtracting the
mean baseline power spectrum. Signiﬁcant ERSP were evaluated
by applying a bootstrap statistical method based on a surrogate
distribution randomly derived from the pre-stimulus onset (ran-
ging from 700 to 50 ms). Statistical signiﬁcance level was set
at po0.01 and only signiﬁcant values were considered in the
analysis. Averaged ERSP values across all trials of a session were
calculated between 8 and 50 Hz (1 Hz bin resolution) over a 20–
300 milliseconds time window, corresponding to the main EEG
activity evoked by TMS. The natural frequency was computed as
the frequency bin with the largest cumulated ERSP over time
(Rosanova et al., 2009). Differences between the frontal natural
frequencies of the four study groups were analyzed with one-way
ANOVA followed by post-hoc Newman–Keuls's tests. Pearson
correlation analysis between medications doses, clinical variables
and natural frequency were performed. Analyses were carried out
using a commercial available software (StatSoft Statistica) and
following standard computational procedures (Hill and Lewicki,
2006).3. Results
Clinical and demographic characteristics of the sample divided
according to diagnosis, and the evoked natural frequencies, are
resumed in Table 1.
All four groups were closely age-matched. Patients with bipolar
or unipolar depression had a similar age at onset and duration of
illness and did not differ on the Hamilton Depression Rating Scale
(HDRS) score. Patients with schizophrenia reported positive and
negative symptoms as measured by PANSS.
Data obtained with the TMS/EEG procedure are resumed in
Fig. 1.
Fig. 1. Top panel: (a) average EEG responses to TMS (grey traces represent the 60 recording channels) for the channel closest to the stimulation site (black trace) over the
premotor area; (b) color-coded: event-related spectral perturbation (ERSP) plots reﬂect the signiﬁcant TMS related changes in amplitude and their duration. Dotted lines
show the frequency with the highest activity (natural frequency). Data are shown from a representative subject from each of the four groups. Bottom panel: individual
natural frequencies values for healthy control subjects (negative controls) and patients with bipolar disorder, major depressive disorder and schizophrenia (positive controls).
(For interpretation of the references to color in this ﬁgure legend, the reader is referred to the web version of this article.)
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(range 21–50 Hz) to frontal cortical perturbation in HC. The main
frequencies of frontal EEG responses to TMS were signiﬁcantly
reduced in patients with either BPD, MDD or SCZ (range 11–27 Hz;
one-way ANOVA: F¼12.31; df¼3,44; p¼0.000006) (Fig. 1c).
Frontal natural frequencies were markedly faster in healthy sub-
jects compared to all the patient groups (post-hoc: p¼0.000485 vs
SCZ, p¼0.000171 vs MDD, and p¼0.000290 vs BP, respectively),
which did not signiﬁcantly differ among themselves.
Correlational analyses between natural frequencies and HDRS,
PANSS scores and medication doses did not show signiﬁcant
effects.4. Discussion
This is the ﬁrst study to provide a TMS/EEG direct measure of
frontal natural oscillations in patients with either BPD or MDD,
compared to HC and SKZ. We extended the ﬁnding of reduced
gamma oscillations, previously reported in SCZ, to mood disorders.
All the three diagnostic conditions were associated with sig-
niﬁcantly slower gamma-band oscillations compared to healthy
controls, and did not differ among themselves.
Common to these psychiatric conditions, a biological under-
pinning of slower gamma-band oscillations could be found in
abnormal ϒ-aminobutyric acid (GABA) neurotransmission.
TMS/EEG can assess cortical inhibition due to inhibitory GABA
interneurons (Daskalakis et al., 2002b), and short cortical inhibi-
tion, interhemispheric inhibition and cortical silent period are
decreased in SCZ (Daskalakis et al., 2002a; Fitzgerald and Daska-
lakis, 2008), MDD (Lefaucheur et al., 2008; Levinson et al., 2010)
and BPD (Levinson et al., 2007). Gamma oscillations may reﬂect
the activity of GABA inhibitory interneurons (Brenner et al., 2009;
Gonzalez-Burgos and Lewis, 2008; Gray and McCormick, 1996;Traub et al., 2005), which produce and sustain complex large-scale
network oscillations in fast frequency bands (40–100 Hz) (Benes
and Berretta, 2001), also generating inhibitory potentials in exci-
tatory pyramidal neurons (Whittington et al., 2011). GABAa
receptor agonizts activate, and antagonists block, high frequency
oscillations (Whittington et al., 1995). Fast parvalbumin-expres-
sing GABA interneurons are necessary for high-frequency oscilla-
tions (Bartos et al., 2007; Uhlhaas et al., 2008), and recent animal
studies demonstrated that their inhibition resulted in gamma
suppression (Sohal et al., 2009). Similarly, decreasing fast-spiking
interneuron activity reduced power and synchronization of
gamma oscillations (Spencer, 2009), while its activation induced
gamma power increase (Cardin et al., 2009).
GABA-ergic neurotransmission has been extensively studied in
psychiatry (Basar, 2013). Post-mortem, low GABA levels were
found in SCZ (Volk and Lewis, 2002) and MDD (Rajkowska et al.,
2007), and the GABA-synthesizing enzyme GAD1 and GAD67 were
altered in SCZ and BPD (Akbarian and Huang, 2006; Gonzalez-
Burgos and Lewis, 2008). In depressed suicide victims GABAa
receptor mRNA expression was reduced in hippocampus, amyg-
dala and frontal cortex (Merali et al., 2004; Poulter et al., 2010).
Reduced density of gabaergic neurons was found in the cortex of
patients with either BPD or SCZ (Benes and Berretta, 2001), with
reduced GABA synthesis in PV-interneurons (Lewis et al., 2005) in
SCZ, suggesting a considerable overlap in inhibitory interneuron
abnormalities in neuropsychiatric disorders. Brain magnetic reso-
nance spectroscopy revealed low GABA levels in prefrontal cortex
of patients with MDD (Hasler et al., 2007; Price et al., 2009) and
BPD (Bhagwagar et al., 2007). Altogether, these data support the
hypothesis that abnormal GABAergic neurotransmission could be
critical to explain the abnormal ϒ-oscillations observed in our
patients (Sohal et al., 2009; Whittington et al., 2000a).
GABAergic neurotransmission is a therapeutic target in mood
disorders and in SCZ. GABA levels increase with mood-stabilizing
P. Canali et al. / Journal of Affective Disorders 184 (2015) 111–115114medications such as valproate and lithium in BPD (Malhi et al.,
2013; O'Donnell et al., 2003). High-frequency repetitive tran-
scranial magnetic stimulation (rTMS) enhances GABA-inhibitory
mechanisms (Daskalakis et al., 2006), and increases gamma-
oscillations in HC (Barr et al., 2009). Indeed, rTMS has been shown
to improve cognitive deﬁcits in MDD (Downar and Daskalakis,
2013) involving synaptic modulation and plasticity (Esser et al.,
2006). Deﬁcits in the modulations of the dopamine system may
trigger the appearance of a defective GABA (Benes and Berretta,
2001). Recent studies reported that clozapine treatment may
potentiate GABA receptors in schizophrenia patients (Liu et al.,
2009).
However, patients with MDD and BPD showed reduced gamma
activity even after complete remission (Ozerdem et al., 2011; Shaw
et al., 2013), suggesting that successful treatment is unable to
normalize these core biological features of the disorders. A recent
study reported a deﬁcit to produce frontal fast oscillations, inde-
pendent of medication status (Minzenberg et al., 2010). Here we
did not ﬁnd any correlation between medication doses and natural
frequencies. We also previously reported that the natural fre-
quencies of different cortical areas, other than the frontal ones,
were not altered in medicated SCZ patients, while if medications
would affect neuronal oscillations one would expect a generalized
effect (Ferrarelli et al., 2012).
Strengths of the present study include a focused research
question, state-of-the-art TMS/EEG methods, and straightforward
effects. However, our experimental setting did not allow to directly
assess the role of deeper structures, such as hippocampus, which
contribute to gamma oscillations (Basar et al., 2001). We obtained
an excellent power to study group differences, but could not
consider other biological markers, gene variants, and their inter-
action with clinical variables. Patients were non drug-naïve.
Recruitment was in a single ethnic group, thus raising the possi-
bility of population stratiﬁcations limiting the generalizability of
the ﬁndings.
In conclusion, these limitations do not bias the main ﬁnding of
signiﬁcantly lower natural frequency of frontal cortico-thalamo-
cortical circuits in patients with BPD, MDD, and SCZ, which sug-
gest their possible relevance as an endophenotype common to
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